US9034921, E019

ID: ALA3703799

Chembl Id: CHEMBL3703799

PubChem CID: 71077007

Max Phase: Preclinical

Molecular Formula: C22H25ClO7

Molecular Weight: 436.89

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c3c(c2Cl)OCC3)cc1

Standard InChI:  InChI=1S/C22H25ClO7/c1-28-13-4-2-11(3-5-13)8-12-9-15(14-6-7-29-21(14)17(12)23)22-20(27)19(26)18(25)16(10-24)30-22/h2-5,9,16,18-20,22,24-27H,6-8,10H2,1H3/t16-,18-,19+,20-,22+/m1/s1

Standard InChI Key:  DEGCWEWWVJMJRO-KQDNOMNESA-N

Associated Targets(Human)

SLC5A2 Tclin Sodium/glucose cotransporter 2 (2000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC5A1 Tclin Sodium/glucose cotransporter 1 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 436.89Molecular Weight (Monoisotopic): 436.1289AlogP: 1.39#Rotatable Bonds: 5
Polar Surface Area: 108.61Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.57CX Basic pKa: CX LogP: 1.64CX LogD: 1.64
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: 1.23

References

1.  (2015)  Diphenylmethane derivatives as SGLT2 inhibitors, 
2. Kong YK, Song KS, Jung ME, Kang M, Kim HJ, Kim MJ..  (2022)  Discovery of GCC5694A: A potent and selective sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes.,  56  [PMID:34813882] [10.1016/j.bmcl.2021.128466]